Semaglutide
Semaglutide (Research-Grade)
Semaglutide is a GLP-1 receptor agonist peptide widely studied for metabolic research. It mimics incretin hormones to regulate appetite, insulin secretion, and glucose metabolism. This is the pure research-grade compound for scientific investigation.
Molekylære data
Renhet
4113.58 g/mol
Molekylvekt
SGL-2026-0501
Batchnummer
HPLC + Mass Spectrometry
Testmetode
Verifisert ren
Labtestet
Modified GLP-1(7-37) analog with C-18 fatty acid chain
Forskningsstudier
Labverifisering
Skann for å verifisere
Batchnummer: SGL-2026-0501
Renhet: 99.1%
Effektprofil
Viktigste fordeler
Passer godt med
Disse peptidene kombineres ofte med Semaglutide for bedre resultater.
Relaterte peptider
Semamax
Semaglutide
Semaglutide is a long-acting GLP-1 receptor agonist originally developed for the treatment of type 2 diabetes. It mimics the action of human GLP-1 to regulate blood sugar, insulin secretion, and appetite. Semaglutide has gained widespread use for weight management.
L-Carnitine
Injectable L-Carnitine
L-Carnitine is a naturally occurring compound that helps transport fatty acids into the mitochondria for energy production. Injectable forms bypass digestion, offering higher bioavailability and faster effects. Commonly used to support fat loss, energy, and athletic performance.